Zinc Chloride Injection
NDC Package 70069-526-25

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Zinc Chloride injection is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition. This formulation utilizes a injection delivery system. Marketed by Somerset Therapeutics, Llc, this product is identified by NDC 70069-526 and is authorized under FDA application ANDA216152.

Identification & Billing

NDC Package Code
70069-526-25
Package Description
25 VIAL, PLASTIC in 1 CARTON / 10 mL in 1 VIAL, PLASTIC (70069-526-01)
Product Code
70069-526
11-Digit Billing Format
70069052625
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Zinc Chloride
Non-Proprietary Name
Zinc Chloride
Substance Name
Zinc Chloride
Dosage Form
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
ZINC CHLORIDE 1 mg/mL
Pharmacologic Class
Usage Information
Zinc chloride injection is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition. Administration helps to maintain zinc serum levels and to prevent depletion of endogenous stores, and subsequent deficiency symptoms.

Regulatory & Marketing

Labeler Name
Somerset Therapeutics, Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA216152
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
10-16-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70069-526-25 identifies a specific commercial package of 25 vial, plastic in 1 carton / 10 ml in 1 vial, plastic (70069-526-01) of Zinc Chloride, a human prescription drug labeled by Somerset Therapeutics, Llc. This injection is formulated for intravenous use and contains zinc chloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Somerset Therapeutics, Llc on October 16, 2024. The current certification is valid through December 31, 2026.

How is this Somerset Therapeutics, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70069052625. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70069-526-25
11-Digit CMS (5-4-2)
70069-0526-25

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.